Showing results (591-600 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|June 19, 2018
CAR T cell therapy for B-cell lymphomasJulio C Chavez, Frederick L LockeBest Practice & Research. Clinical Haematology|June 19, 2018
CARs and other T cell therapies for MM: The clinical experienceSophia Danhof, Michael Hudecek, Eric L SmithBest Practice & Research. Clinical Haematology|June 19, 2018
Toxicities associated with immunotherapies for hematologic malignanciesMark B Leick, Marcela V MausBest Practice & Research. Clinical Haematology|November 24, 2018
Should immunologic strategies be incorporated into frontline ALL therapy?Cecilie Utke Rank, Wendy StockBest Practice & Research. Clinical Haematology|November 24, 2018
Is there a standard of care for relapsed AML?Bruno C MedeirosBest Practice & Research. Clinical Haematology|November 24, 2018
Is it time to routinely incorporate MRD into practice?Farhad RavandiBest Practice & Research. Clinical Haematology|November 24, 2018
Can haploidentical transplantation meet all patients' needs?Daniel WeisdorfBest Practice & Research. Clinical Haematology|November 24, 2018
Why is a 3-year NRM following allogeneic transplantation still stuck at approximately 20%?John BarrettBest Practice & Research. Clinical Haematology|March 15, 2017
Treatment of splenic marginal zone lymphomaChristina Kalpadakis, Gerassimos A Pangalis, Maria K Angelopoulou, et al.Best Practice & Research. Clinical Haematology|March 15, 2017
Possible novel agents in marginal zone lymphomaPier Luigi Zinzani, Alessandro BroccoliPageof 113